3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Conditions
Lymphoma
1600
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1282
Lymphoma, Non-Hodgkin
1231
Leukemia, Lymphocytic, Chronic, B-Cell
1090
Lymphoma, Follicular
979
Lymphoma, Large B-Cell, Diffuse
853
Leukemia
790
Hodgkin Disease
777
Lymphoma, Mantle-Cell
675
Leukemia, Myeloid, Acute
540
Burkitt Lymphoma
507
Lymphoma, B-Cell, Marginal Zone
490
Multiple Myeloma
483
Myelodysplastic Syndromes
371
Lymphoma, Large-Cell, Immunoblastic
366
Recurrence
363
Lymphoma, T-Cell, Cutaneous
313
Neoplasms
309
Waldenstrom Macroglobulinemia
307
Lymphoma, Large-Cell, Anaplastic
254
Mycosis Fungoides
252
Lymphoma, B-Cell
231
Sezary Syndrome
229
Blast Crisis
210
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
208
Myeloproliferative Disorders
205
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
189
Neoplasms, Plasma Cell
188
Leukemia, Myeloid, Accelerated Phase
186
Leukemia, Myeloid, Chronic-Phase
179
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Arthritis, Juvenile
×
Lymphoid
×
Clear all
NCT00964210
2011-04-15
HPV
Murdoch Childrens Research Institute
Phase 3
Completed
240 enrolled